amyotrophic lateral sclerosis

ALS Patients Approved For More Stem CellsThree patients with amyotrophic lateral sclerosis will be permitted to receive a second dose of stem cells delivered directly to the spinal cord, in a clinical trial being led by the University of Michigan's Eva Feldman, M.D.
Synthetic Biologics Launches Free Investor Relations Mobile ApplicationSynthetic Biologics Inc. (NYSE Amex: SYN) Thursday announced the release of its investor relations mobile iPhone App, called the "SYN IR" App, now available for free at the Apple App Store on the iPhone or iPad or at
UM Part Of New Study Of Stem Cell Injections in Lou Gehrig's DiseaseThe first published results from an early-stage clinical trial show that spinal cord stem cells can be delivered safely into the spines of patients with the condition commonly known as Lou Gehrig's disease, opening the door for further research on this innovative approach.
Adeona Reports Positive Study Results For Zinc Treatment Of ALSPharma startup Adeona and its research partner report no safety issues related to high doses of zinc to slow the effects of Lou Gehrig's Disease
UM Research May Help Treat ALS
Best Winter Festivals In Metro Detroit
Thanksgiving Parade Guide

Watch & Listen